TokenPost topic

Amivantamab

1 TokenPost story is tagged Amivantamab. The newest appear first.

Latest Amivantamab stories

• J&J Reports 77% Response Rate in HPV-Unrelated Head and Neck Cancer Group

  The rate was 66% across all 29 evaluable participants. A randomized Phase 3 study will compare the regimen with pembrolizumab, platinum chemotherapy and 5-fluorouracil.

  Oct 25, 2026, 6:09 PM EDT · Business